Brainstorm Cell Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
01 Oct 24 | BuyUS$6,292 | Chaim Lebovits | Individual | 1,836 | US$3.43 | |
19 Jul 24 | SellUS$22,069 | Ibrahim Dagher | Individual | 4,200 | US$5.25 | |
28 May 24 | BuyUS$7,774 | Chaim Lebovits | Individual | 1,000 | US$7.77 | |
22 May 24 | BuyUS$30,475 | Chaim Lebovits | Individual | 3,333.34 | US$9.60 | |
13 May 24 | BuyUS$18,865 | Chaim Lebovits | Individual | 2,666.67 | US$7.35 | |
07 May 24 | BuyUS$75,482 | Chaim Lebovits | Individual | 13,420.01 | US$5.63 | |
19 Apr 24 | BuyUS$7,798 | Chaim Lebovits | Individual | 1,000 | US$7.80 | |
18 Apr 24 | BuyUS$131,411 | Chaim Lebovits | Individual | 16,338.14 | US$8.19 |
Insider Trading Volume
Insider Buying: BCLI insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 133,389 | 2.51% |
Institutions | 284,599 | 5.35% |
Hedge Funds | 459,843 | 8.65% |
Individual Insiders | 658,868 | 12.4% |
General Public | 3,778,909 | 71.1% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 74.7%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
459,843 | US$616.7k | -12.9% | 0.01% | |||
275,838 | US$370.0k | 0% | no data | |||
233,333 | US$312.9k | 0% | no data | |||
128,919 | US$172.9k | 0% | no data | |||
100,709 | US$135.1k | 0% | no data | |||
80,960 | US$108.6k | 4.25% | no data | |||
45,521 | US$61.1k | 41% | no data | |||
25,174 | US$33.8k | -2.27% | no data | |||
24,146 | US$32.4k | -14.5% | no data | |||
22,676 | US$30.4k | 0% | no data | |||
15,623 | US$21.0k | 0% | 0.01% | |||
12,667 | US$17.0k | -24.9% | no data | |||
10,667 | US$14.3k | 0% | no data | |||
10,389 | US$13.9k | 0% | no data | |||
9,700 | US$13.0k | 0% | no data | |||
8,465 | US$11.4k | 0% | no data | |||
7,817 | US$10.5k | 0% | no data | |||
7,490 | US$10.0k | 0% | no data | |||
6,343 | US$8.5k | -14.5% | no data | |||
4,470 | US$6.0k | 0% | no data | |||
4,362 | US$5.9k | 0% | no data | |||
4,350 | US$5.8k | 0% | no data | |||
3,778 | US$5.1k | 0% | no data | |||
3,539 | US$4.7k | 0% | no data | |||
3,518 | US$4.7k | 83.2% | no data |